The Enterprise Value as of November 2024 (TTM) for Revolution Medicines, Inc. (RVMD) is 9.43B

According to Revolution Medicines, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 9.43B. This represents a change of 71.08% compared to the average of 5.51B of the last 4 quarters.

Revolution Medicines, Inc. (RVMD) Historical Enterprise Value (quarterly & annually)

How has RVMD Enterprise Value performed in the past?

The mean historical Enterprise Value of Revolution Medicines, Inc. over the last ten years is 1.79B. The current 9.43B Enterprise Value has changed 52.57% with respect to the historical average. Over the past ten years (40 quarters), RVMD's Enterprise Value was at its highest in in the September 2024 quarter at 7.45B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Revolution Medicines, Inc. (RVMD) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Revolution Medicines, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Revolution Medicines, Inc. (RVMD) Average Enterprise Value

How has RVMD Enterprise Value performed in the past?

The current Enterprise Value of Revolution Medicines, Inc. (RVMD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Revolution Medicines, Inc. (RVMD) Enterprise Value vs. Peers

How is RVMD’s Enterprise Value compared to its peers?

Revolution Medicines, Inc.’s Enterprise Value is greater than Blueprint Medicines Corporation (6.36B), greater than Sana Biotechnology, Inc. (551.82M), greater than Kymera Therapeutics, Inc. (2.89B), greater than Monte Rosa Therapeutics, Inc. (439.72M), greater than TCR2 Therapeutics Inc. (79.12M), greater than Black Diamond Therapeutics, Inc. (139.97M), greater than Atreca, Inc. (-8620212.00), greater than Passage Bio, Inc. (24.72M), greater than Akero Therapeutics, Inc. (2.00B), greater than Avidity Biosciences, Inc. (4.80B), greater than Protagonist Therapeutics, Inc. (2.65B), greater than Stoke Therapeutics, Inc. (457.69M), greater than Homology Medicines, Inc. (-103303255.00), greater than C4 Therapeutics, Inc. (307.45M), greater than Agios Pharmaceuticals, Inc. (2.98B), greater than Nurix Therapeutics, Inc. (1.49B),

Build a custom stock screener for Revolution Medicines, Inc. (RVMD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revolution Medicines, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Revolution Medicines, Inc. (RVMD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Revolution Medicines, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.